IDRx - Ownership and Business Overview

Life ScienceCompany

IDRx Ownership

Who owns IDRx?

IDRx is owned by GSK. It was acquired on January 13, 2025.

IDRx Business Overview

Where is IDRx headquartered?

IDRx is headquartered in Cambridge, Massachusetts.

What sector is IDRx in?

IDRx is a life science company.

When was IDRx founded?

IDRx was founded in 2022.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Join Mergr to view all 62 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 59 by strategics.

IDRx

IDRx, Inc.

245 Main Street, Second Floor,
Cambridge, Massachusetts 02142
United States,
www.idrx.com

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx was founded in 2022 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 212,929
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 206K M&A Transactions
  • 208K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.